Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:24-30

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.-P.
Right arrow Articles by Carretero, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.-P.
Right arrow Articles by Carretero, O. A.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 1999;34:24-30.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Endothelial Nitric Oxide Gene Knockout Mice

Cardiac Phenotypes and the Effect of Angiotensin-Converting Enzyme Inhibitor on Myocardial Ischemia/Reperfusion Injury

Xiao-Ping Yang; Yun-He Liu; Edward G. Shesely; Manohar Bulagannawar; Fang Liu; Oscar A. Carretero

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich.

Correspondence to Xiao-Ping Yang, MD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. E-mail xpyang1{at}hfhs.org

Abstract—We tested the hypothesis that nitric oxide (NO) released by endothelial NO synthase (eNOS) is not only important in blood pressure regulation but also involved in cardiac function and remodeling and in the cardioprotective effect of angiotensin-converting enzyme inhibitors (ACEi). With the use of a 2D Doppler echocardiography system equipped with a 15-MHz linear transducer, we evaluated left ventricular (LV) morphology and function in conscious eNOS knockout mice (eNOS-/-; n=15) and their wild-type littermates (eNOS+/+; n=16). We also studied whether in eNOS-/- mice (1) myocardial ischemia/reperfusion injury is more severe and (2) the cardioprotective effect of ACEi is diminished or absent. In comparison with the wild type, eNOS-/- mice had significantly increased systolic blood pressure (128±3 versus 108±5 mm Hg; P<0.001) and decreased heart rate (531±22 versus 629±18 bpm; P<0.001) associated with increased LV posterior wall thickness (0.80±0.04 versus 0.64±0.02 mm; P<0.001) and LV mass (18.3±0.9 versus 13.1±0.5 mg/10 g body weight; P<0.01). Despite hypertension and LV hypertrophy, LV chamber dimension, shortening fraction and ejection fraction (indicators of LV contractility), and cardiac output did not differ between the 2 strains, which indicates that LV function in eNOS-/- mice is well compensated. We also found that in eNOS+/+ mice, ACEi decreased the ratio of myocardial infarct size to area at risk from 62.7±3.9% to 36.3±1.6% (P<0.001), whereas in eNOS-/- mice this effect of ACEi was almost abolished: the ratio of myocardial infarct size to area at risk was 67.2±2.9% in the vehicle-treated group and 62.7±3.9% in mice treated with ACEi. Moreover, infarct size in vehicle-treated eNOS-/- mice was not significantly different from eNOS+/+ mice given the same treatment. We concluded that (1) endothelium-derived NO plays an important role in the regulation of blood pressure homeostasis; (2) NO released under basal conditions has no significant impact on cardiac function; and (3) ACEi protect the heart against ischemia/reperfusion injury in mice and that this effect is mediated in part by endothelium-derived NO.


Key Words: nitric oxide • myocardial ischemia • myocardial reperfusion injury • mice, knockout • angiotensin-converting enzyme inhibitors • echocardiography




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
J. L. Durand, S. Mukherjee, F. Commodari, A. P. De Souza, D. Zhao, F. S. Machado, H. B. Tanowitz, and L. A. Jelicks
Role of NO Synthase in the Development of Trypanosoma cruzi-Induced Cardiomyopathy in Mice
Am J Trop Med Hyg, May 1, 2009; 80(5): 782 - 787.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. S. A. Capettini, S. F. Cortes, M. A. Gomes, G. A. B. Silva, J. L. Pesquero, M. J. Lopes, M. M. Teixeira, and V. S. Lemos
Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2503 - H2511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Raher, H. Thibault, K. K. Poh, R. Liu, E. F. Halpern, G. Derumeaux, F. Ichinose, W. M. Zapol, K. D. Bloch, M. H. Picard, et al.
In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3 Deficient Mice
Circulation, September 11, 2007; 116(11): 1250 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Xu, O. A. Carretero, C.-X. Lin, M. A. Cavasin, E. G. Shesely, J. J. Yang, T. L. Reudelhuber, and X.-P. Yang
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1900 - H1907.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Sun, O. A. Carretero, J. Xu, N.-E. Rhaleb, F. Wang, C. Lin, J. J. Yang, P. J. Pagano, and X.-P. Yang
Lack of Inducible NO Synthase Reduces Oxidative Stress and Enhances Cardiac Response to Isoproterenol in Mice With Deoxycorticosterone Acetate-Salt Hypertension
Hypertension, December 1, 2005; 46(6): 1355 - 1361.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Xu, O. A. Carretero, Y. Sun, E. G. Shesely, N.-E. Rhaleb, Y.-H. Liu, T.-D. Liao, J. J. Yang, M. Bader, and X.-P. Yang
Role of the B1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction
Hypertension, April 1, 2005; 45(4): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Guthrie, L. M. Curtis, R. N. Mames, G. G. Simon, M. B. Grant, and E. W. Scott
The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells
Blood, March 1, 2005; 105(5): 1916 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Xiang, J. Kong, S. Chen, L.-P. Cao, G. Qiao, W. Zheng, W. Liu, X. Li, D. G. Gardner, and Y. C. Li
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E125 - E132.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Wang, N. Ahmad, M. Kudo, and M. Ashraf
Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1125 - H1131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Momken, P. Lechene, R. Ventura-Clapier, and V. Veksler
Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H914 - H920.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Brede, W. Roell, O. Ritter, F. Wiesmann, R. Jahns, A. Haase, B. K. Fleischmann, and L. Hein
Cardiac Hypertrophy Is Associated With Decreased eNOS Expression in Angiotensin AT2 Receptor-Deficient Mice
Hypertension, December 1, 2003; 42(6): 1177 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Brain in the Brawn: The Neuronal Nitric Oxide Synthase as a Regulator of Myogenic Tone
Circ. Res., October 3, 2003; 93(7): 586 - 588.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. P. Cappola, L. Cope, A. Cernetich, L. A. Barouch, K. Minhas, R. A. Irizarry, G. Parmigiani, S. Durrani, T. Lavoie, E. P. Hoffman, et al.
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy
Physiol Genomics, June 24, 2003; 14(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. N Van Vliet, L. L Chafe, and J.-P. Montani
Characteristics of 24 h Telemetered Blood Pressure in eNOS-Knockout and C57Bl/6J Control Mice
J. Physiol., May 15, 2003; 549(1): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. McNamara, R. Holubkov, L. Postava, R. Ramani, K. Janosko, M. Mathier, G. A. MacGowan, S. Murali, A. M. Feldman, and B. London
Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure
Circulation, April 1, 2003; 107(12): 1598 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. A. Ortiz and J. L. Garvin
Cardiovascular and renal control in NOS-deficient mouse models
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P B Massion and J-L Balligand
Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice
J. Physiol., January 1, 2003; 546(1): 63 - 75.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Brunner, R. Maier, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer
Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase
Cardiovasc Res, January 1, 2003; 57(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. J. Endo, K. Kojima, K. Nakamura, Y. Matsuzaki, and T. Onitsuka
Nitric oxide inhalation prompts weaning from the right ventricular assist device: Evaluation under continuous-flow biventricular assistance
J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 739 - 749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. A. Janssen and J. F. M. Smits
Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. R. Sharp, S. P. Jones, D. M. Rimmer, and D. J. Lefer
Differential response to myocardial reperfusion injury in eNOS-deficient mice
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2422 - H2426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Y. H. Wong, S. Kulandavelu, K. J. Whiteley, D. Qu, B. L. Langille, and S. L. Adamson
Maternal cardiovascular changes during pregnancy and postpartum in mice
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H918 - H925.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y.-H. Liu, J. Xu, X.-P. Yang, F. Yang, E. Shesely, and O. A. Carretero
Effect of ACE Inhibitors and Angiotensin II Type 1 Receptor Antagonists on Endothelial NO Synthase Knockout Mice With Heart Failure
Hypertension, February 1, 2002; 39(2): 375 - 381.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Scherrer-Crosbie, R. Ullrich, K. D. Bloch, H. Nakajima, B. Nasseri, H. T. Aretz, M. L. Lindsey, A.-C. Vancon, P. L. Huang, R. T. Lee, et al.
Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice
Circulation, September 11, 2001; 104(11): 1286 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Fischer, A. A. MacLean, M. Liu, B. Kalirai, and S. Keshavjee
Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 573 - 580.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Hill, M. Karimi, W. Kutschke, R. L. Davisson, K. Zimmerman, Z. Wang, R. E. Kerber, and R. M. Weiss
Cardiac Hypertrophy Is Not a Required Compensatory Response to Short-Term Pressure Overload
Circulation, June 20, 2000; 101(24): 2863 - 2869.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-P. Yang, Y.-H. Liu, N.-E. Rhaleb, N. Kurihara, H. E. Kim, and O. A. Carretero
Echocardiographic assessment of cardiac function in conscious and anesthetized mice
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1967 - H1974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. R. Sharp, S. P. Jones, D. M. Rimmer, and D. J. Lefer
Differential response to myocardial reperfusion injury in eNOS-deficient mice
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2422 - H2426.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X.-P. Yang, Y.-H. Liu, D. Mehta, M. A. Cavasin, E. Shesely, J. Xu, F. Liu, and O. A. Carretero
Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice
Circ. Res., May 25, 2001; 88(10): 1072 - 1079.
[Abstract] [Full Text] [PDF]